Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (91-100 of 338) with videos related to

Pageof 34
Sort By:
Journal of Human Hypertension|May 24, 2000
Calcium antagonists, ACE inhibitors, and the risk of cancer in hypertensive patientsE Grossman, F H Messerli
Archives of Internal Medicine|November 5, 1999
The use of sublingual nifedipine: a continuing concernF H Messerli, E Grossman
European Heart Journal|March 13, 1999
Diuretics, beta-blockers, and gin and tonicF H Messerli, E Grossman
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 16, 1998
Fixed drug combinations in the treatment of hypertension: how to identify the optimal doseF H Messerli, L Michalewicz
Drugs|January 1, 1992
Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?F H Messerli, F Soria
Archives of Internal Medicine|March 13, 1995
High blood pressure. A side effect of drugs, poisons, and foodE Grossman, F H Messerli
Annals of Internal Medicine|August 15, 1996
Diabetic and hypertensive heart diseaseE Grossman, F H Messerli
Cardiology Clinics|February 1, 1986
Risks for obesityC Amodeo, F H Messerli
American Heart Journal|August 1, 1997
Safety of heart rate-lowering calcium antagonists: lessons from controlled trialsF H Messerli, L Michalewicz
Drugs|January 1, 1986
Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertensionF H Messerli, R Schmieder
Pageof 34

Showing results (91-100 of 338) with videos related to

Sort By:
Pageof 34
Journal of Human Hypertension|May 24, 2000
Calcium antagonists, ACE inhibitors, and the risk of cancer in hypertensive patientsE Grossman, F H Messerli
Archives of Internal Medicine|November 5, 1999
The use of sublingual nifedipine: a continuing concernF H Messerli, E Grossman
European Heart Journal|March 13, 1999
Diuretics, beta-blockers, and gin and tonicF H Messerli, E Grossman
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 16, 1998
Fixed drug combinations in the treatment of hypertension: how to identify the optimal doseF H Messerli, L Michalewicz
Drugs|January 1, 1992
Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?F H Messerli, F Soria
Archives of Internal Medicine|March 13, 1995
High blood pressure. A side effect of drugs, poisons, and foodE Grossman, F H Messerli
Annals of Internal Medicine|August 15, 1996
Diabetic and hypertensive heart diseaseE Grossman, F H Messerli
Cardiology Clinics|February 1, 1986
Risks for obesityC Amodeo, F H Messerli
American Heart Journal|August 1, 1997
Safety of heart rate-lowering calcium antagonists: lessons from controlled trialsF H Messerli, L Michalewicz
Drugs|January 1, 1986
Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertensionF H Messerli, R Schmieder
Pageof 34